Total Payments
$5,774
2024 Payments
$820.04
Companies
26
Transactions
374
Medicare Patients
1,192
Medicare Billing
$246,466
Payment Breakdown by Category
Food & Beverage$5,774 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,774 | 374 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,340 | 91 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $809.39 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $750.11 | 49 | $0 (2024) |
| ABBVIE INC. | $520.04 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $425.91 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $333.86 | 20 | $0 (2019) |
| Merck Sharp & Dohme LLC | $314.22 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $243.52 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $217.18 | 16 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $137.64 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $820.04 | 43 | ABBVIE INC. ($180.10) |
| 2023 | $670.88 | 36 | PFIZER INC. ($233.00) |
| 2022 | $842.82 | 48 | PFIZER INC. ($200.56) |
| 2021 | $916.45 | 61 | PFIZER INC. ($193.34) |
| 2020 | $242.01 | 16 | Janssen Pharmaceuticals, Inc ($64.31) |
| 2019 | $1,067 | 76 | Janssen Pharmaceuticals, Inc ($217.45) |
| 2018 | $607.72 | 47 | PFIZER INC. ($162.76) |
| 2017 | $606.85 | 47 | Janssen Pharmaceuticals, Inc ($148.97) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Vascular | ||||||
| 10/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/15/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: DIABETES | ||||||
| 07/30/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/27/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/20/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 269 | 578 | $184,789 | $52,421 |
| 2022 | 6 | 272 | 617 | $178,892 | $55,816 |
| 2021 | 5 | 298 | 692 | $196,139 | $65,482 |
| 2020 | 5 | 353 | 763 | $216,580 | $72,746 |
Total Patients
1,192
Total Services
2,650
Medicare Billing
$246,466
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 120 | 389 | $110,087 | $34,861 | 31.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 42 | $23,604 | $5,320 | 22.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 57 | 57 | $19,665 | $4,949 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 71 | $14,200 | $4,269 | 30.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 19 | $17,233 | $3,023 | 17.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 389 | $95,423 | $30,450 | 31.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 70 | $32,130 | $10,573 | 32.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 35 | $22,265 | $5,814 | 26.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 66 | $11,101 | $3,568 | 32.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 37 | 37 | $9,533 | $2,926 | 30.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $8,440 | $2,484 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 125 | 456 | $107,616 | $36,958 | 34.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 28 | 65 | $38,415 | $11,320 | 29.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 57 | 57 | $26,163 | $8,980 | 34.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 65 | 65 | $15,860 | $5,442 | 34.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 49 | $8,085 | $2,780 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 141 | 485 | $110,090 | $38,795 | 35.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 45 | 97 | $57,327 | $17,088 | 29.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 54 | 54 | $23,436 | $8,223 | 35.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 76 | 76 | $17,680 | $6,005 | 34.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 51 | $8,047 | $2,635 | 32.7% |
About Dr. Mugurel Sorescu, M.D
Dr. Mugurel Sorescu, M.D is a Internal Medicine healthcare provider based in N Wilkesboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639141344.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mugurel Sorescu, M.D has received a total of $5,774 in payments from pharmaceutical and medical device companies, with $820.04 received in 2024. These payments were reported across 374 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,774).
As a Medicare-enrolled provider, Sorescu has provided services to 1,192 Medicare beneficiaries, totaling 2,650 services with total Medicare billing of $246,466. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location N Wilkesboro, NC
- Active Since 02/06/2006
- Last Updated 10/25/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639141344
Products in Payments
- ELIQUIS (Drug) $1,527
- XARELTO (Drug) $795.65
- ENTRESTO (Drug) $660.16
- DALVANCE (Drug) $406.51
- SAMSCA (Drug) $333.86
- JARDIANCE (Drug) $294.89
- DIFICID (Drug) $273.85
- LOKELMA (Drug) $202.14
- TEFLARO (Drug) $156.76
- XIFAXAN (Drug) $125.38
- PRADAXA (Drug) $104.31
- LEQVIO (Drug) $89.95
- RELISTOR (Drug) $64.23
- SOLIRIS (Drug) $64.05
- BROVANA (Drug) $60.78
- Ozempic (Drug) $52.24
- WATCHMAN (Device) $42.43
- VERQUVO (Drug) $40.37
- BASAGLAR (Drug) $35.35
- ULTOMIRIS (Drug) $25.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.